BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7406381)

  • 1. Vitamin D metabolite levels in oncogenic osteomalacia.
    Sweet RA; Males JL; Hamstra AJ; DeLuca HF
    Ann Intern Med; 1980 Aug; 93(2):279-80. PubMed ID: 7406381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies in a patient with tumor-induced hypophosphatemic osteomalacia.
    Ryan WG; Gitelis S; Charters JR
    Calcif Tissue Int; 1986 Jun; 38(6):358-62. PubMed ID: 3089559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual vignette.
    Behera KK; Paul TV; Arulselvan S; Varghese AM
    Endocr Pract; 2008 Dec; 14(9):1191. PubMed ID: 19158059
    [No Abstract]   [Full Text] [Related]  

  • 4. Oncogenic osteomalacia secondary to nasal tumor with decreased urinary excretion of cAMP.
    Kawai Y; Morimoto S; Sakaguchi K; Yoshino H; Yotsui T; Hirota S; Inohara H; Nakagawa T; Hattori K; Kubo T; Yang J; Fujiwara N; Ogihara T
    J Bone Miner Metab; 2001; 19(1):61-4. PubMed ID: 11156476
    [No Abstract]   [Full Text] [Related]  

  • 5. Oncogenic osteomalacia: loss of hypophosphatemia might be the key to avoid misdiagnosis.
    Chang CV; Conde SJ; Luvizotto RA; Nunes VS; Bonates MC; Felicio AC; Lindsey SC; Moraes FH; Tagliarini JV; Mazeto GM; Kopp P; Nogueira CR
    Arq Bras Endocrinol Metabol; 2012 Nov; 56(8):570-3. PubMed ID: 23295300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic osteomalacia presenting as bilateral stress fractures of the tibia.
    Ohashi K; Ohnishi T; Ishikawa T; Tani H; Uesugi K; Takagi M
    Skeletal Radiol; 1999 Jan; 28(1):46-8. PubMed ID: 10068075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Craniofacial hemangiopericytoma associated with oncogenic osteomalacia: case report.
    Sandhu FA; Martuza RL
    J Neurooncol; 2000; 46(3):241-7. PubMed ID: 10902855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid detection of intact FGF-23 in tumor tissue from patients with oncogenic osteomalacia.
    Mannstadt M; Lorente C; Jüppner H
    Clin Chem; 2008 Jul; 54(7):1252-4. PubMed ID: 18593970
    [No Abstract]   [Full Text] [Related]  

  • 10. Bilateral subtrochanteric fractures in tumour-induced osteomalacia caused by a nasal haemangiopericytoma.
    Burnand H; Samuels A; Hagan I; Sawant N; Mutimer J
    Hip Int; 2012; 22(2):227-9. PubMed ID: 22547377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone scan in tumor-induced osteomalacia.
    Lee HK; Sung WW; Solodnik P; Shimshi M
    J Nucl Med; 1995 Feb; 36(2):247-9. PubMed ID: 7830124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic osteomalacia from pterygopalatine fossa mass.
    Savage CR; Zimmer LA
    J Laryngol Otol; 2009 Sep; 123(9):1052-4. PubMed ID: 19250593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
    Seijas R; Ares O; Sierra J; Pérez-Dominguez M
    Arch Orthop Trauma Surg; 2009 Apr; 129(4):533-9. PubMed ID: 19125258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity.
    Miyauchi A; Fukase M; Tsutsumi M; Fujita T
    J Clin Endocrinol Metab; 1988 Jul; 67(1):46-53. PubMed ID: 2837500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor expression studies indicate that HEM-1 is unlikely to be the active factor in oncogenic osteomalacia.
    Nelson AE; Mason RS; Hogan JJ; Diamond T; Robinson BG
    Bone; 1998 Dec; 23(6):549-53. PubMed ID: 9855464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe hypophosphatemia in a 79-year-old man.
    Meng QH; Wagar EA
    Clin Chem; 2014 Jul; 60(7):928-31. PubMed ID: 24973428
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypophosphoremic osteomalacia and hemangiopericytoma of the vault of the cranium].
    Crouzet J; Camus JP; Gatti JM; Descamps H; Beraneck L
    Rev Rhum Mal Osteoartic; 1980; 47(7-9):523-8. PubMed ID: 7423113
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypophosphoremic osteomalacia secondary to benign connective tissue tumors: a report on three unusual cases with vitamin D metabolites measurements (author's transl)].
    Camus JP; Crouzet J; Prier A; Guillemant S; Ulmann A; Koeger AC
    Ann Med Interne (Paris); 1980; 131(7):422-6. PubMed ID: 7224450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
    Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
    G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor-induced osteomalacia caused by nasal hemangiopericytoma: a case report].
    Huang PY; Li YZ; Yang XM; Yu BQ; Guo L; Guo ZT; Li SS
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Aug; 54(8):615-617. PubMed ID: 31434378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.